Genomics and Personalized Medicine Act of 2007
The source supplies the latest action, but no lifecycle stage.
Latest action (23 Mar 2007): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
The Genomics and Personalized Medicine Act of 2007 would direct the Secretary of Health and Human Services to establish an interagency working group to coordinate federal genomics initiatives. It would also create a national biobanking distributed database for genomic and health information, and a grant program for biobanking initiatives at academic medical centers. Additionally, the bill aims to improve training in genetics and genomics for healthcare professionals and to study incentives for developing companion diagnostic tests.
The bill would affect various entities, including federal agencies involved in health and research, academic medical centers, and healthcare professionals who diagnose and treat patients. It would also impact individuals by potentially improving the accuracy of disease diagnosis, the safety of drugs, and the identification of new treatments through personalized medicine approaches.
This bill was introduced in the Senate in 2007 and referred to the Committee on Health, Education, Labor, and Pensions. As it has only been introduced, it would need to be passed by both the Senate and the House of Representatives and signed by the President to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Genomics and Personalized Medicine Act of 2007 - Directs the Secretary of Health and Human Services to: (1) establish the Genomics and Personalized Medicine Interagency Working Group (IWG) to facilitate collaboration, coordination, and integration of activities among federal agencies relating to genomic research and initiatives; (2) establish a national biobanking distributed database for the collection and integration of genomic data and associated environmental and clinical health information; (3) establish a grant program for academic medical centers and other entities to develop or expand biobanking initiatives; (4) improve genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders; (5) contract with the National Academy of Sciences to study incentives to encourage companion diagnostic test development; and (6) make information available on the safety and efficacy of genetic tests and commission a study for improving federal oversight and regulation of such tests.
Requires the Director of the Centers for Disease Control and Prevention to: (1) conduct an analysis of the public health impact of direct-to-consumer marketing of genetic tests; and (2) expand efforts to educate the public about genomics and its health applications.
Timeline
23 Mar 2007
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 976 do?
- The Genomics and Personalized Medicine Act of 2007 would direct the Secretary of Health and Human Services to establish an interagency working group to coordinate federal genomics initiatives. It would also create a national biobanking distributed database for genomic and health information, and a grant program for biobanking initiatives at academic medical centers. Additionally, the bill aims to improve training in genetics and genomics for healthcare professionals and to study incentives for developing companion diagnostic tests. The bill would affect various entities, including federal agencies involved in health and research, academic medical centers, and healthcare professionals who diagnose and treat patients. It would also impact individuals by potentially improving the accuracy of disease diagnosis, the safety of drugs, and the identification of new treatments through personalized medicine approaches. This bill was introduced in the Senate in 2007 and referred to the Committee on Health, Education, Labor, and Pensions. As it has only been introduced, it would need to be passed by both the Senate and the House of Representatives and signed by the President to become law.
- Has S. 976 become law?
- The source does not supply a confirmed lifecycle stage for S. 976. Check the latest action and official source below.
- Who sponsored S. 976?
- S. 976 was sponsored by Sen. Obama, Barack [D-IL] (D-IL), with 2 cosponsors.
- What's the latest action on S. 976?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (23 Mar 2007).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Obama, Barack [D-IL]
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.